本报告期

上年同期

本报告期比上年同期增减

营业收入(元)

1,779,721,282.94

1,453,762,580.16

22.42%

归属于上市公司股东的净利润(元)

241,048,769.16

193,971,062.64

24.27%

归属于上市公司股东的扣除非经常性损 益的净利润(元)

240,695,962.14

195,065,092.25

23.39%

经营活动产生的现金流量净额(元)

279,191,996.92

260,466,831.53

7.19%

基本每股收益(元/股)

0.30

0.25

20.00%

稀释每股收益(元/股)

0.30

0.24

25.00%

加权平均净资产收益率

8.41%

8.52%

-0.11%

本报告期末

上年度末

本报告期末比上年度末增减

总资产(元)

5,048,351,880.73

4,602,844,037.74

9.68%

归属于上市公司股东的净资产(元)

2,991,419,922.18

2,677,219,800.98

11.74%

营业收入

营业成本

毛利

营业收入比上年同期增减

营业成本比上年同期增减

毛利比上年同期增减

分行业

工业

1,418,533,961.42

833,630,975.82

41.23%

21.51%

18.36%

1.56%

贸易

361,187,321.52

352,279,841.31

2.47%

26.12%

25.87%

0.19%

合计

1,779,721,282.94

1,185,910,817.13

33.37%

22.42%

20.50%

1.07%

分产品

医药中间体

182,612,974.38

115,411,297.84

36.80%

25.39%

12.43%

7.28%

农药中间体

1,108,031,296.52

622,151,793.68

43.85%

18.81%

15.57%

1.58%

其它

127,889,690.52

96,067,884.30

24.88%

43.42%

51.65%

-4.08%

工业业务合计

1,418,533,961.42

833,630,975.82

41.23%

21.51%

18.36%

1.56%

贸易业务合计

361,187,321.52

352,279,841.31

2.47%

26.12%

25.87%

0.19%

合计

1,779,721,282.94

1,185,910,817.13

33.37%

22.42%

20.50%

1.07%

分地区

工业-国内市场

430,925,411.66

243,427,148.20

43.51%

47.13%

27.12%

8.89%

工业-国外市场

987,608,549.76

590,203,827.62

40.24%

12.93%

15.09%

-1.12%

其中：美洲区

497,324,998.53

260,438,394.90

47.63%

0.30%

2.17%

-0.96%

欧洲区

390,912,765.75

261,603,579.07

33.08%

37.47%

35.59%

0.93%

亚太区

99,370,785.48

68,161,853.65

31.41%

5.35%

4.86%

0.33%

工业合计

1,418,533,961.42

833,630,975.82

41.23%

21.51%

18.36%

1.56%

贸易-国内

52,604,515.83

46,268,944.12

12.04%

69.26%

70.77%

-0.78%

贸易-国外

308,582,805.69

306,010,897.19

0.83%

20.87%

21.06%

-0.16%

贸易合计

361,187,321.52

352,279,841.31

2.47%

26.12%

25.87%

0.19%

总计

1,779,721,282.94

1,185,910,817.13

33.37%

22.42%

20.50%

1.07%